Chang SS - Search Results

1

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.

Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. Among authors: chang ss. J Urol. 2024 Jul;212(1):74-86. doi: 10.1097/JU.0000000000004020. Epub 2024 May 5. J Urol. 2024. PMID: 38704840 Clinical Trial.

2

Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.

Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS. Dutta SC, et al. Among authors: chang ss. J Urol. 2001 Aug;166(2):490-3. J Urol. 2001. PMID: 11458053

3

Radical cystectomy is safe in elderly patients at high risk.

Chang SS, Alberts G, Cookson MS, Smith JA Jr. Chang SS, et al. J Urol. 2001 Sep;166(3):938-41. J Urol. 2001. PMID: 11490250

4

Estimated blood loss and transfusion requirements of radical cystectomy.

Chang SS, Smith JA Jr, Wells N, Peterson M, Kovach B, Cookson MS. Chang SS, et al. J Urol. 2001 Dec;166(6):2151-4. J Urol. 2001. PMID: 11696725

5

Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial.

Chang SS, Alberts G, Wells N, Smith JA Jr, Cookson MS. Chang SS, et al. J Urol. 2001 Dec;166(6):2178-80. doi: 10.1016/s0022-5347(05)65529-2. J Urol. 2001. PMID: 11696730 Clinical Trial.

6

Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.

Chang SS, Baumgartner RG, Wells N, Cookson MS, Smith JA Jr. Chang SS, et al. J Urol. 2002 Jan;167(1):208-11. J Urol. 2002. PMID: 11743307

7

Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.

Nixon RG, Chang SS, Lafleur BJ, Smith JA JA, Cookson MS. Nixon RG, et al. Among authors: chang ss. J Urol. 2002 Feb;167(2 Pt 1):502-5. doi: 10.1016/S0022-5347(01)69073-6. J Urol. 2002. PMID: 11792906

8

Lymphoma presenting as a solitary renal hilar mass.

Chang SS, Nayak R, Cookson MS. Chang SS, et al. Urology. 2002 Jan;59(1):134-5. doi: 10.1016/s0090-4295(01)01458-3. Urology. 2002. PMID: 11796299 No abstract available.

9

Routine postoperative intensive care monitoring is not necessary after radical cystectomy.

Chang SS, Cookson MS, Hassan JM, Wells N, Smith JA Jr. Chang SS, et al. J Urol. 2002 Mar;167(3):1321-4. J Urol. 2002. PMID: 11832723

10

Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.

Clark T, Chang SS, Cookson MS. Clark T, et al. Among authors: chang ss. J Urol. 2002 Apr;167(4):1795. J Urol. 2002. PMID: 11912421 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,335 results

Search Page

Filters